lifestance health group announces results of annual shareholder meeting

LifeStance Health Group, Inc. (NASDAQ:LFST), a $2.3 billion healthcare services company currently trading at $5.93, held its annual meeting of stockholders on Tuesday, where several key proposals were voted upon. According to InvestingPro data, the company has shown strong revenue growth of 16.3% over the last twelve months. The meeting took place in Scottsdale, Arizona, and the results were disclosed in a recent SEC filing.

The stockholders elected Teresa DeLuca, Katherine Wood, and Eric Palmer to the Board of Directors as Class I members, each to serve a three-year term. DeLuca received 292,308,309 votes in favor, with 30,914,443 votes withheld and 23,980,047 broker non-votes. Wood garnered 245,528,506 votes for, 77,694,246 votes withheld, and 23,980,047 broker non-votes. Palmer was elected with 318,312,297 votes for, 4,910,455 votes withheld, and 23,980,047 broker non-votes.

Additionally, the stockholders ratified the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025. This proposal received 346,473,203 votes in favor, 58,358 against, and 671,238 abstentions.

In a non-binding advisory vote, the stockholders approved the compensation for the company’s named executive officers. The vote concluded with 295,914,020 in favor, 26,682,137 against, 626,595 abstentions, and 23,980,047 broker non-votes.

The information regarding the meeting and its outcomes was based on a press release statement from the company. LifeStance Health Group is incorporated in Delaware and is classified under health services.

In other recent news, LifeStance Health reported its first quarter 2025 earnings, achieving positive net income for the first time. The company saw an 11% year-over-year increase in revenue, reaching $333 million, and a 25% rise in adjusted EBITDA. UBS analyst Kevin Caliendo upgraded LifeStance Health’s stock rating from Neutral to Buy, with a new price target of $8.50, citing significant growth potential. Caliendo highlighted the company’s strategic shift from stock-based to cash-based incentives, which is expected to save approximately $40 million annually in net income within four years. Additionally, LifeStance Health announced the appointment of Vaughn Paunovich as the new Chief Technology Officer, effective June 9, 2025. Paunovich brings over two decades of experience in healthcare technology, having previously worked at Amwell and UnitedHealth Group (NYSE:UNH). The company continues to focus on expanding its clinician base and services, including virtual visits, which accounted for 71% of all visits during the first quarter. These developments reflect LifeStance Health’s ongoing efforts to enhance its financial health and operational efficiency.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.